Replies to post #71829 on PharmaCyte Biotech Inc (PMCB)

[mwebb1514]

I think the $10 estimate was after pancreatic cancer study proved cell in a box worked. Diabetes study would get a boost in legitimacy and press coverage after that.

[PINKribbon]

You make a valid point.

There has been many great conversations on this board of PharmaCyte's amazing achievements and advancements over the years leading up to today.

So, now that this exciting time is upon us I would love to engage in a conversation with all the great posters here as to what they truly believe the "possibilities" of what they might think can occur with our near billion mark share count.

I would like to start the conversation by saying we can't ignore, nor deny the possibility of a reverse split that would make the share price and share count ratio more attractive.

A R/S would be my worst nightmare, but I am preparing myself as I continue to buy as much as I can, when I can.

I truly do wish us all the cancer patients and shareholders the very best of luck.